Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor

Journal of NeuroVirology

Volumn 19, Issue 3, 2013, Pages 219-227

  Schwartz, Lynnae ^a   Spitsin, Sergei V ^a,b   Meshki, John ^a,b   Tuluc, Florin ^a,b   Douglas, Steven D ^a,b   Wolfe, John H ^a,b,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aprepitant; HIV 1; Human fetal brain cells; Neurokinin 1 receptor; Substance P

Indexed keywords

CALCIUM; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P;

ARTICLE; BRAIN CELL; CALCIUM MOBILIZATION; CELL CULTURE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IMPEDANCE; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

BRAIN; CALCIUM; ELECTRIC IMPEDANCE; FETUS; GENE EXPRESSION; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; ION TRANSPORT; MORPHOLINES; NEUROKININ-1 RECEPTOR ANTAGONISTS; NEURONS; PRIMARY CELL CULTURE; RECEPTORS, NEUROKININ-1; SUBSTANCE P; VIRUS ACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84879814024     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-013-0166-x     Document Type: Article

References (41)

1. Amadesi S, Reni C, Katare R, Meloni M, Oikawa A, Beltrami AP et al (2012) Role for substance P-based nociceptive signaling in progenitor cell activation and angiogenesis during ischemia in mice and in human subjects. Circulation 125(14):1774-1786. doi: 10.1161/CIRCULATIONAHA.111.089763
2. Azzari C, Rossi ME, Resti M, Caldini AL, Lega L, Galli L et al (1992) Changed levels of substance P and somatostatin in HIV-positive children. Pediatr Med Chir 14(6):577-581
3. Boutet A, Salim H, Taoufik Y, Lledo PM, Vincent JD, Delfraissey JF, Tardieu M (2001) Isolated human astrocytes are not susceptible to infection by M-and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4. Glia 34(3):165-177, http://proxy.library.upenn.edu: 2082/pubmed/11329179
4. Brackis-Cott E, Kang E, Dolezal C, Abrams EJ, Mellins CA (2009) The impact of perinatal HIV infection on older school-aged children's and adolescent's receptive language and word recognition skills. AIDS Patient Care STDs 23(6):415-421. doi: 10.1089/apc.2008.0197
5. Caberlotto L, Hurd YL, Murdock P, Wahlin JP, Melotto S, Corsi M et al (2003) Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain. Eur J Neurosci 17(9):1736-1746. doi: 1046/j.1460-9568.2003.02600.x
6. Chauhan VS, Sterka DG, Gray DL, Bost KL, Marriott I (2008) Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi. J Immunol 180(12):8241-8249, http://www.jimmunol.org/ content/180/12/8241
7. Chernova I, Lai J-P, Li H, Schwartz L, Tuluc F, Korchak HM et al (2009) Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1-receptor (NK1R). J Leukoc Biol 85(1):154-164. doi: 10.1189/jlb.0408260
8. Crocker SJ, Frausto RF, Whitton JL, Milner R (2008) A novel method to establish microglia-free astrocyte cultures: comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia. Glia 56(11):1187-1198. doi: 10.1002/glia.20689
9. Douglas SD, Leeman SE (2011) Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation. Ann NY Acad Sci 1217:83-95. doi: 10.1111/j.1749-6632.2010.05826.x
10. Douglas SD, Ho WZ, Gettes DR, Cnaan A, Zhao H, Leserman J et al (2001) Elevated substance P levels in HIV-infected men. AIDS 15(15):2043-2045
11. Douglas SD, Cnaan A, Lynch KG, Benton T, Zhao H, Gettes DR et al (2008) Elevated substance P levels in HIV-infected women in comparison to HIV-negative women. AIDS Res Hum Retroviruses 24(3):375-378. doi: 10.1089/aid.2007.0207
12. Hahn YK, Podhaizer EM, Hauser KF, Knapp PE (2012) HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation. Glia 60:1871-1887. doi: 10.1002/glia.22403
13. Ho WZ, Douglas SD (2004) Substance P and neurokinin-1 receptor modulation of HIV. J Neuroimmunol 157(1-2):48-55, http://proxy.library.upenn.edu: 2110/10.1016/j.jneuroim.2004.08.022
14. Jeremy RJ, Kim S, Nozyce M, Nachman S, McIntosh K, Pelton SI, Yogev R, Wiznia A, Johnson GM, Krogstad P, Stanley K, for the Pediatric AIDS Clinical trials Group (PACTG) 338 & 377 Study Teams (2005) Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics 115(2):380-387. doi: 10.1542/peds.2004-1108
15. Kärkkäinen V, Louhivuori V, Castrén ML, Åkerman KE (2009) Neurotransmitter responsiveness during early maturation of neural progenitor cells. Differentiation 77:188-198. doi: 10.1016/j.diff.2008.10.005
16. Lai JP, Zhan GX, Campbell DE, Douglas SD, Ho WZ (2000) Detection of Substance P and its receptor in human fetal microglia. Neuroscience 101(4):1137-1144, http://proxy.library.upenn.edu: 2110/10.1016/S0306-4522(00) 00398-5
17. Lai JP, Ho WZ, Zhan GX, Yi Y, Collman RG, Douglas SD (2001) Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc Natl Acad Sci U S A 98(7):3970-3975. doi: 10.1073/pnas. 071052298
18. Lai JP, Ho WZ, Kilpatrick LE, Wang X, Tuluc F, Korchak HM et al (2006) Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation. Proc Natl Acad Sci U S A 103(20):7771-7776. doi: 10.1073/pnas.0602563103
19. Lai JP, Cnaan A, Zhao H, Douglas SD (2008a) Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions. J Neurosci Methods 168:127-133. doi: 10.1016/j.jneumeth.2007.10.004
20. Lai JP, Lai S, Tuluc F, Tansky MF, Kilpatrick LE, Leeman SE et al (2008b) Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor. Proc Natl Acad Sci U S A 105(34):12605-12610. doi: 10.1073/pnas.0806632105
21. Lawrence DM, Durham LC, Schwartz L, Seth P, Maric D, Major EO (2004) Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J Virol 78:7319-7328. doi: 10.1128/jvi.78.14.7319-7328.2004
22. Li Y, Douglas SD, Ho WZ (2000) Human stem cells express substance P gene and its receptor. J Hematother Stem Cell Res 9(4):445-452
23. Manak MM, Moshkoff DA, Nguyen LY, Meshki J, Tebas P, Tuluc F et al (2010) Anti-HIV activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals. AIDS 24(18):2789-2796. doi: 10.1097/QAD.0b013e3283405c33
24. McNamara LA, Ganesh JA, Collins KL (2012) Latent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NK-κB activation. J Virol 86(17):9337-9350. doi: 10.1128/JVI.00895-1
25. Mellins CA, Brackis-Cott E, Leu C-S, Elkington KS, Dolezal C, Wiznia A et al (2009) Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroconverters. J Child Psychol Psychiatry 50(9):1131-1138. doi: 10.1111/j.1469-7610.2009.02069.x
26. Meshki J, Douglas SD, Lai JP, Schwartz L, Kilpatrick LE, Tuluc F (2009) Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism. J Biol Chem 284(14):9280-9289. doi: 10.1074/jbc.M808825200
27. Meshki J, Douglas SD, Hu M, Leeman SE, Tuluc F (2011) Substance P induces rapid and transient membrane blebbing in U373MG cells in a p21-activated kinase-dependent manner. PLoS One 6(9):e25332. doi: 10.1371/journal.pone. 0025332, Accessed 6 Aug 2012
28. Messam CA, Hou J, Major EO (2000) Coexpression of nestin in neural and glial cells in the developing human CNS define by a human-specific anti-nestin antibody. Exp Neurol 161(2):585-596, http://proxy.library.upenn.edu: 2110/10.1006/exnr.1999.7319
29. Messam CA, Hou J, Gronostajski RM, Major EO (2003) Lineage pathway of human brain progenitor cells identified by JC virus susceptibility. Ann Neurol 53(5):636-646. doi: 10.1002/ana.10523
30. Palmieri C, Trimboli F, Puca A, Fiume G, Scala G, Quinto I (2004) Inhibition of HIV-1 replication in primary human monocytes by the IκB-αS32/36A repressor of NF-κB. Retrovirology. doi: 10.1186/1742-4690-1-45
31. Park S-W, Yan Y-P, Satriotomo I, Vemuganti R, Dempsey RJ (2007) Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions. J Neurosurg 107:593-599, http://proxy.library.upenn.edu: 2082/pubmed/17886560
32. Rothenaigner I, Kramer S, Ziegler M, Wolff H, Kleinschmidt A, Brack-Werner R (2007) Long-term HIV-1 infection of neural progenitor populations. AIDS 21(17):2271-2281. doi: 10.1097/QAD.0b013e3282f12f27
33. Sabri F, Tresoldi E, Di Stefano M, Polo S, Monaco MC, Verani A, Fiore JR, Lusso P, Major E, Chiodi F, Scarlatti G (1999) Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology 264(2):370-384, http://proxy.library.upenn.edu: 2110.10.1006/viro.1999.9998
34. Saura J (2007) Microglial cells in astroglial cultures: a cautionary note. J Neuroinflammation 4:26. doi: 10.1186/1742-2094-4-26
35. Schwartz L, Civitello L, Dunn-Pirio A, Ryschkewitsch S, Berry E, Cavert W et al (2007) Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue. J Neurovirol 13(3):274-283. doi: 10.1080/13550280701344975
36. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V (2002) The tachykinin peptide family. Pharmacol Rev 54(2):285-322. doi: 10.1124/pr.54.2.285
37. Tebas P, Tuluc F, Barrett JS, Wagner W, Kim D, Zhao D et al (2011) A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults. PLoS One 6(9):e24180. doi: 10.1371/journal.pone. 0024180, Accessed 10 Oct 2012
38. Tuluc F, Lai JP, Kilpatrick LE, Evans DL, Douglas SD (2009) Neurokinin 1 receptor isoforms and the control of innate immunity. Trends Immunol 30(6):271-276, http://proxy.library.upenn.edu: 2110/10.1016/j.it.2009.03.006
39. Vinet-Oliphant H, Alvarez X, Buza E, Borda JT, Mohan M, Aye PP, Tuluc F, Douglas SD, Lackner AA (2010) Neurokinin-1 receptor (NK-1R) expression in the brains of SIV-infected rhesus macaques: implications for substance P in NK1-R immune cell trafficking into the CNS. Am J Pathol 177(3):1286-1297, http://proxy.library.upenn.edu: 2110/10.2353/ajpath.2010.091109
40. Wang X, Douglas SD, Lai J-P, Tuluc F, Tebas P, Ho W-Z (2007) Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro (2007). J Neuroimmune Pharmacol 2(1):42-48. doi: 10.1007/s11481-006-9059-6
41. Wang X, Douglas SD, Song L, Wang YJ, Ho WZ (2008) Neurokinin-1 receptor antagonist (aprepitant) suppresses HIV-1 infection of microglia/macrophages. J Neuroimmune Pharmacol 3(4):257-264. doi: 10.1007/s11481-008-9117-3